ConductScience.org, home

Comparison · NCT03442322-cfeb54c2

Transdisciplinary Approach vs Multidisciplinary Approach: Dispensing of Psychotropic Medications

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Transdisciplinary Approach vs Multidisciplinary Approach: Dispensing of Psychotropic Medications. Trial comparisons, record NCT03442322-cfeb54c2. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03442322-cfeb54c2

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2060.1760.24wilson
Risk in group 20.1850.1660.205wilson
Risk difference, group 1 minus group 20.0215-0.01480.0602newcombe hybrid score
Risk ratio, group 1 over group 21.120.9251.35log
Odds ratio, group 1 over group 21.150.9071.45log
Number needed to treat, for one more participant with the outcome on Transdisciplinary Approach than on Multidisciplinary Approach46.5from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Transdisciplinary Approach
This approach is integrated across disciplines and provides core training for all providers, staff members, and stakeholders, using a common language to address care concerns and support continuity and sustainability.
125606OG000
Group 2Multidisciplinary ApproachThis is a problem-based approach that draws on the expertise of individual healthcare providers (e.g., occupational therapy) to address care concerns.2891,564OG001

Outcome

Type
PRIMARY
Title
Dispensing of Psychotropic Medications
Description
Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention.
Time frame
12-month period (months 7-12)
Population
Population includes all nursing home residents with dementia in participating nursing homes (NHs) with valid data in the Minimum Data Set (MDS) assessments.

Source ClinicalTrials.gov

Trial

Title
Optimizing Care for Patients With Dementia
NCT number
NCT03442322
Phases
NA
Conditions
Alzheimer Disease
Interventions
transdisciplinary approach, multidisciplinary approach
Lead sponsor
University of Pittsburgh
Results first posted
2024-08-19

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03442322-cfeb54c2